First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease
Henryk Barthel
Abstract
On May 28, the Food and Drug Administration approved 18F-flortaucipir, also known as AV1451, under the trademark name Tauvid (Avid Radiopharmaceuticals), for estimation of the density and distribution of aggregated tau neurofibrillary tangles in adults with cognitive impairment who are being
Topics & Concepts
Cognitive impairmentAlzheimer's diseaseFood and drug administrationMedicineDiseaseNuclear medicinePathologyNeurosciencePharmacologyPsychologyDementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsDiet and metabolism studies